Ondřej Uher


Mgr. Ondřej Uher

 

supervisor: RNDr. Jindřich Chmelař Ph.D. 

co-supervisor: RNDr. Jan Ženka, CSc.

topic of dissertation thesis: Study of Cancer Immunotherapy Mechanisms in Pancreatic Adenocarcinoma and Pheochromocytoma Murine Models

Since December 2018 at The Eunice Kennedy Shriver Nation Institute of Child Health and Human Development (NICHD), NIH,  Bethesda, Maryland, laboratory of Karel Pacák, D.Sc., M.D., Ph.D.

e-mail: uheron00@prf.jcu.cz

tel.: +420 732 143 829

 

Publications: 

Uher O., Caisová V., Hansen P., Kopecký J., Chmelař J., Zhuang Z., Ženka J., Pacák K. (2019): Coley´s immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity. Semin Oncol 46: 385-392.

Caisová V., Li L., Gupta G., Jochmanová I., Jha A., Uher O., Huynh T.T., Miettinen M., Pang Y., Abunimer L., Niu G., Chen X., Ghayee H.K., Taïeb D., Zhuang Z., Ženka J., Pacák K. (2019): The significant reduction or complete eradication of subcutaneous and metastatic lesions in a pheochromocytoma mouse model after immunotherapy using mannan-BAM, TLR ligands, and anti-CD40. Cancers 11: 654.

Caisová, V., Uher, O., Nedbalová, P., Jochmanová, I., Kvardová, K., Masáková, K., Krejčová, G., Paďouková, L., Chmelař, J., Kopecký, J. and Ženka, J. (2018): Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis. International immunopharmacology,59: 86-96.